297 related articles for article (PubMed ID: 8964863)
1. The interaction of a type A retroviral particle and class II human leukocyte antigen susceptibility genes in the pathogenesis of Graves' disease.
Jaspan JB; Sullivan K; Garry RF; Lopez M; Wolfe M; Clejan S; Yan C; Tenenbaum S; Sander DM; Ahmed B; Bryer-Ash M
J Clin Endocrinol Metab; 1996 Jun; 81(6):2271-9. PubMed ID: 8964863
[TBL] [Abstract][Full Text] [Related]
2. The interaction of MHC and Gm in liability to autoimmune thyroid disease.
Nagataki S
Mol Biol Med; 1986 Feb; 3(1):73-84. PubMed ID: 3007922
[TBL] [Abstract][Full Text] [Related]
3. Immunogenetics of Hashimoto's and Graves' diseases.
Tamai H; Uno H; Hirota Y; Matsubayashi S; Kuma K; Matsumoto H; Kumagai LF; Sasazuki T; Nagataki S
J Clin Endocrinol Metab; 1985 Jan; 60(1):62-6. PubMed ID: 3838076
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
5. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
6. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
7. Gene Map of the HLA Region, Graves' Disease and Hashimoto Thyroiditis, and Hematopoietic Stem Cell Transplantation.
Sasazuki T; Inoko H; Morishima S; Morishima Y
Adv Immunol; 2016; 129():175-249. PubMed ID: 26791860
[TBL] [Abstract][Full Text] [Related]
8. Failure to demonstrate cell-mediated immune responses to thyroid antigens in Graves' disease using in vitro assays of lymphokine-mediated migration inhibition.
Ludgate ME; Ratanachaiyavong S; Weetman AP; Hall R; McGregor AM
J Clin Endocrinol Metab; 1985 Jan; 60(1):98-102. PubMed ID: 3871093
[TBL] [Abstract][Full Text] [Related]
9. Limited genetic susceptibility to severe Graves' ophthalmopathy: no role for CTLA-4 but evidence for an environmental etiology.
Villanueva R; Inzerillo AM; Tomer Y; Barbesino G; Meltzer M; Concepcion ES; Greenberg DA; MacLaren N; Sun ZS; Zhang DM; Tucci S; Davies TF
Thyroid; 2000 Sep; 10(9):791-8. PubMed ID: 11041456
[TBL] [Abstract][Full Text] [Related]
10. A study of human leukocyte D locus related antigens in Graves' disease.
Farid NR; Sampson L; Noel EP; Barnard JM; Mandeville R; Larsen B; Marshall WH; Carter ND
J Clin Invest; 1979 Jan; 63(1):108-13. PubMed ID: 105012
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a retroviral trigger in Graves' disease.
Jaspan JB; Luo H; Ahmed B; Tenenbaum S; Voss T; Sander DM; Bollinger K; Baquet T; Garry RF
Autoimmunity; 1995; 20(2):135-42. PubMed ID: 7578870
[TBL] [Abstract][Full Text] [Related]
12. Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406.
Uchigata Y; Kuwata S; Tsushima T; Tokunaga K; Miyamoto M; Tsuchikawa K; Hirata Y; Juji T; Omori Y
J Clin Endocrinol Metab; 1993 Jul; 77(1):249-54. PubMed ID: 8325948
[TBL] [Abstract][Full Text] [Related]
13. Class II major histocompatibility complex antigen expression and cellular interactions in thyroid glands of Graves' disease.
Matsunaga M; Eguchi K; Fukuda T; Kurata A; Tezuka H; Shimomura C; Otsubo T; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1986 Apr; 62(4):723-8. PubMed ID: 3081570
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of thyrocyte HLA class II expression in a wide variety of thyroid diseases: relationship with lymphocytic infiltration and thyroid autoantibodies.
Lucas-Martin A; Foz-Sala M; Todd I; Bottazzo GF; Pujol-Borrell R
J Clin Endocrinol Metab; 1988 Feb; 66(2):367-75. PubMed ID: 3276724
[TBL] [Abstract][Full Text] [Related]
15. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study.
Heward JM; Allahabadia A; Daykin J; Carr-Smith J; Daly A; Armitage M; Dodson PM; Sheppard MC; Barnett AH; Franklyn JA; Gough SC
J Clin Endocrinol Metab; 1998 Oct; 83(10):3394-7. PubMed ID: 9768636
[TBL] [Abstract][Full Text] [Related]
16. The epidemiology of Graves' disease: evidence of a genetic and an environmental contribution.
Hemminki K; Li X; Sundquist J; Sundquist K
J Autoimmun; 2010 May; 34(3):J307-13. PubMed ID: 20056533
[TBL] [Abstract][Full Text] [Related]
17. MHC-extended haplotypes in families of patients with Graves' disease.
Ratanachaiyavong S; Lloyd L; Darke C; McGregor AM
Hum Immunol; 1993 Feb; 36(2):99-111. PubMed ID: 8096501
[TBL] [Abstract][Full Text] [Related]
18. Thyroid autoimmune disease in a large Newfoundland family: the influence of HLA.
Farid NR; Barnard JM; Marshall WH; Woolfrey I; O'Driscoll RF
J Clin Endocrinol Metab; 1977 Dec; 45(6):1165-72. PubMed ID: 579351
[TBL] [Abstract][Full Text] [Related]
19. [The effects of HLA class II genes on the susceptibility to autoimmune thyroid diseases].
Shinagawa H
Fukuoka Igaku Zasshi; 1990 Feb; 81(2):97-111. PubMed ID: 2328940
[TBL] [Abstract][Full Text] [Related]
20. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production.
Tomer Y; Greenberg DA; Barbesino G; Concepcion E; Davies TF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1687-93. PubMed ID: 11297604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
